TRPC6型
足细胞
狭缝隔膜
尼福林
蛋白尿
肾
下调和上调
肾脏疾病
生物
细胞生物学
癌症研究
内科学
内分泌学
医学
瞬时受体电位通道
受体
基因
遗传学
作者
Clemens C. MoCombining Diaeresisller,Changli Wei,Mehmet M. Altintas,Jing Li,Anna Greka,Takamoto Ohse,Jeffrey W. Pippin,Maria Pia Rastaldi,Stefan Wawersik,Susan C. Schiavi,Anna Henger,Matthias Kretzler,Stuart J. Shankland,Jochen Reiser
标识
DOI:10.1681/asn.2006091010
摘要
Exercise intolerance is an important comorbidity in patients with CKD. Anaerobic threshold (AT) determines the upper limits of aerobic exercise and is a measure of cardiovascular reserve. This study investigated the prognostic capacity of AT on survival in patients with advanced CKD and the effect of kidney transplantation on survival in those with reduced cardiovascular reserve. Using cardiopulmonary exercise testing, cardiovascular reserve was evaluated in 240 patients who were waitlisted for kidney transplantation between 2008 and 2010, and patients were followed for ≤5 years. Survival time was the primary endpoint. Cumulative survival for the entire cohort was 72.6% (24 deaths), with cardiovascular events being the most common cause of death (54.2%). According to Kaplan–Meier estimates, patients with AT <40% of predicted peak VO2 had a significantly reduced 5-year cumulative overall survival rate compared with those with AT ≥40% (P<0.001). Regarding the cohort with AT <40%, patients who underwent kidney transplantation (6 deaths) had significantly better survival compared with nontransplanted patients (17 deaths) (hazard ratio, 4.48; 95% confidence interval, 1.78 to 11.38; P=0.002). Survival did not differ significantly among patients with AT ≥40%, with one death in the nontransplanted group and no deaths in the transplanted group. In summary, this is the first prospective study to demonstrate a significant association of AT, as the objective index of cardiovascular reserve, with survival in patients with advanced CKD. High-risk patients with reduced cardiovascular reserve had a better survival rate after receiving a kidney transplant.
科研通智能强力驱动
Strongly Powered by AbleSci AI